发布求助
文献互助 智能选刊 最新文献

Revue Medicale de Bruxelles最新文献

筛选
英文 中文
Complex Regional Pain Syndrome in children and adolescents 儿童和青少年的复杂局部疼痛综合征
Revue Medicale de Bruxelles Pub Date : 2022-01-01 DOI: 10.30637/2022.21-056
C. Richard, C. Fonteyne
{"title":"Complex Regional Pain Syndrome in children and adolescents","authors":"C. Richard, C. Fonteyne","doi":"10.30637/2022.21-056","DOIUrl":"https://doi.org/10.30637/2022.21-056","url":null,"abstract":"","PeriodicalId":39361,"journal":{"name":"Revue Medicale de Bruxelles","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"69381422","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Contribution of inhaled methoxyflurane in the management of shoulder dislocation in the emergency department 吸入甲氧基氟醚在急诊科肩关节脱位治疗中的作用
Revue Medicale de Bruxelles Pub Date : 2022-01-01 DOI: 10.30637/2022.21-060
L. Troppmann, J. Cavenaile
{"title":"Contribution of inhaled methoxyflurane in the management of shoulder dislocation in the emergency department","authors":"L. Troppmann, J. Cavenaile","doi":"10.30637/2022.21-060","DOIUrl":"https://doi.org/10.30637/2022.21-060","url":null,"abstract":"","PeriodicalId":39361,"journal":{"name":"Revue Medicale de Bruxelles","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"69381432","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Urinary incontinence determinants and risk factors in adolescents and young women in democratic republic of Congo 刚果民主共和国青少年和年轻妇女尿失禁的决定因素和危险因素
Revue Medicale de Bruxelles Pub Date : 2022-01-01 DOI: 10.30637/2022.21-070
J. Nako Iyongo, A. Punga Maole Mongalembe, A. Nkodila Natuhoyila, JP Esika Mokumo, T. Mosolongo, M. Loposso Nkumu
{"title":"Urinary incontinence determinants and risk factors in adolescents and young women in democratic republic of Congo","authors":"J. Nako Iyongo, A. Punga Maole Mongalembe, A. Nkodila Natuhoyila, JP Esika Mokumo, T. Mosolongo, M. Loposso Nkumu","doi":"10.30637/2022.21-070","DOIUrl":"https://doi.org/10.30637/2022.21-070","url":null,"abstract":"","PeriodicalId":39361,"journal":{"name":"Revue Medicale de Bruxelles","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"69381494","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Risk of undernutrition and proven undernutrition: update of the diagnostic criteria 营养不良和已证实营养不良的风险:更新诊断标准
Revue Medicale de Bruxelles Pub Date : 2022-01-01 DOI: 10.30637/2022.21-082
J. Preiser, S. Farine
{"title":"Risk of undernutrition and proven undernutrition: update of the diagnostic criteria","authors":"J. Preiser, S. Farine","doi":"10.30637/2022.21-082","DOIUrl":"https://doi.org/10.30637/2022.21-082","url":null,"abstract":"","PeriodicalId":39361,"journal":{"name":"Revue Medicale de Bruxelles","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"69381559","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
BIJUVA®, the only bioidentical HRT, combining estradiol and progesterone in a single pill : finally available in Belgium, after the USA (approval in 2018 by the Food and Drug Administration) ! BIJUVA®，唯一的生物同质激素替代疗法，将雌二醇和黄体酮结合在一颗药丸中:终于在比利时上市，仅次于美国(2018年获得美国食品和药物管理局批准)!
Revue Medicale de Bruxelles Pub Date : 2022-01-01 DOI: 10.30637/2022.22-042
M. L'Hermitte
{"title":"BIJUVA®, the only bioidentical HRT, combining estradiol and progesterone in a single pill : finally available in Belgium, after the USA (approval in 2018 by the Food and Drug Administration) !","authors":"M. L'Hermitte","doi":"10.30637/2022.22-042","DOIUrl":"https://doi.org/10.30637/2022.22-042","url":null,"abstract":"","PeriodicalId":39361,"journal":{"name":"Revue Medicale de Bruxelles","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"69381752","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
When pediatric psychiatry and genetics tangle: Psychiatric consequences of an unbalanced phenylketonuria during childhood and genetic regard 当儿科精神病学和遗传学纠缠:儿童时期苯丙酮尿不平衡的精神后果和遗传学方面
Revue Medicale de Bruxelles Pub Date : 2022-01-01 DOI: 10.30637/2022.21-012
O. Van Ormelingen, S. Marchini, M. Delhaye
{"title":"When pediatric psychiatry and genetics tangle: Psychiatric consequences of an unbalanced phenylketonuria during childhood and genetic regard","authors":"O. Van Ormelingen, S. Marchini, M. Delhaye","doi":"10.30637/2022.21-012","DOIUrl":"https://doi.org/10.30637/2022.21-012","url":null,"abstract":"","PeriodicalId":39361,"journal":{"name":"Revue Medicale de Bruxelles","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"69381762","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Indication for neutralizing monoclonal antibodies for treatment of COVID-19 in real life: the big gap with controlled randomized trials 中和单克隆抗体在现实生活中治疗COVID-19的适应症:与对照随机试验的巨大差距
Revue Medicale de Bruxelles Pub Date : 2022-01-01 DOI: 10.30637/2022.22-043
M. Hildebrand, J. Goffard
{"title":"Indication for neutralizing monoclonal antibodies for treatment of COVID-19 in real life: the big gap with controlled randomized trials","authors":"M. Hildebrand, J. Goffard","doi":"10.30637/2022.22-043","DOIUrl":"https://doi.org/10.30637/2022.22-043","url":null,"abstract":"Anti-SARS-CoV-2 neutralizing monoclonal antibodies treatments have been studied through randomized controlled trials and have demonstrated efficacy for prevention and early COVID-19 treatment. Their use in real life is different from studies in many points. Variant changes, vaccination coverage, treated groups with nAbs which are different from clinical trials are topics discussed in this paper.","PeriodicalId":39361,"journal":{"name":"Revue Medicale de Bruxelles","volume":"26 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"69381789","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Benign non cancereous disease and radiotherapy : current indications in 2021 良性非癌性疾病和放疗:2021年的当前适应症
Revue Medicale de Bruxelles Pub Date : 2022-01-01 DOI: 10.30637/2022.20-098
P. van Houtte, M. Roelandts, P. Martinive, B. Donneaux, D. Van Gestel
{"title":"Benign non cancereous disease and radiotherapy : current indications in 2021","authors":"P. van Houtte, M. Roelandts, P. Martinive, B. Donneaux, D. Van Gestel","doi":"10.30637/2022.20-098","DOIUrl":"https://doi.org/10.30637/2022.20-098","url":null,"abstract":"","PeriodicalId":39361,"journal":{"name":"Revue Medicale de Bruxelles","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"69381368","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Rosai-Dorfman disease with lymph node, bone, and kidney involvement Rosai-Dorfman病伴淋巴结、骨和肾脏受累
Revue Medicale de Bruxelles Pub Date : 2022-01-01 DOI: 10.30637/2022.21-043
I. Chabchoub, C. Dammak, M. Snoussi, I. Maaloul, R. Kallel, D. Chebbi, F. Frikha, Z. Bahloul
{"title":"Rosai-Dorfman disease with lymph node, bone, and kidney involvement","authors":"I. Chabchoub, C. Dammak, M. Snoussi, I. Maaloul, R. Kallel, D. Chebbi, F. Frikha, Z. Bahloul","doi":"10.30637/2022.21-043","DOIUrl":"https://doi.org/10.30637/2022.21-043","url":null,"abstract":"","PeriodicalId":39361,"journal":{"name":"Revue Medicale de Bruxelles","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"69381395","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Rybelsus® (semaglutide) : the oral treatment of type 2 diabetes by a GLP-1 receptor agonist becomes reality ! Rybelsus®(semaglutide): GLP-1受体激动剂口服治疗2型糖尿病成为现实!
Revue Medicale de Bruxelles Pub Date : 2022-01-01 DOI: 10.30637/2022.22-015
L. Crenier
{"title":"Rybelsus® (semaglutide) : the oral treatment of type 2 diabetes by a GLP-1 receptor agonist becomes reality !","authors":"L. Crenier","doi":"10.30637/2022.22-015","DOIUrl":"https://doi.org/10.30637/2022.22-015","url":null,"abstract":"","PeriodicalId":39361,"journal":{"name":"Revue Medicale de Bruxelles","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"69381664","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
首页 上一页 下一页 尾页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：481959085
Book学术官方微信